The relationship between NT-proBNP and Depression in Patients with Heart Failure

被引:0
作者
YingHui GAO [1 ]
Lin LIU [2 ]
Yu WANG [3 ]
Chao LIU [3 ,4 ]
机构
[1] Peking University Hepatology Institute, Peking University People's Hospital, Peking University
[2] Nanlou Respiratory Disease Department, Chinese PLA General Hospital
[3] The First Cardiology Division, The First Hospital of Hebei Medical University
[4] Cardiovascular Research Center,Hebei Medical University
关键词
D O I
暂无
中图分类号
R541.6 [血液循环衰竭]; R749.4 [情感性精神病];
学科分类号
1002 ; 100201 ; 100205 ;
摘要
<正>To the editor We read the article entitled"Depression is associated with increased C-reactive protein levels in patients with heart failure and hyperuricemia".In this article WANG,et al.[1]reported that serum hs-CRP may be an independent marker for severity of depression in heart failure patients with hyperuricemia.The authors suggested that the relationship between the role of inflammation in the pathogenesis of depression and heart failure may help to devise new
引用
收藏
页码:715 / 716
页数:2
相关论文
共 50 条
[31]   Risk scores or NT-proBNP for prognostic stratification of heart failure patients? [J].
Passino, C. ;
Arzilli, C. ;
Ripoli, A. ;
Gabutti, A. ;
Senni, M. ;
Emdin, M. .
EUROPEAN HEART JOURNAL, 2017, 38 :107-107
[32]   Barostim, NT-proBNP, And Clinical Outcomes In Heart Failure [J].
Abraham, Joseph d. ;
Abraham, William t. ;
Lindenfeld, Joann ;
Weaver, Fred a. ;
Zannad, Faiez ;
Wilks, Seth ;
Rogers, Tyson ;
Zile, Michael r. .
JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
[33]   The importance of serial NT-proBNP testing in heart failure [J].
Hernandez, AF ;
Stebbins, A ;
Troughton, RW ;
Hartmann, F ;
Bettencourt, P ;
Bayes-Genis, A ;
Hasselblad, V ;
Newby, LK .
CIRCULATION, 2005, 112 (17) :U405-U405
[34]   Relationship Between Myocardial NPPB Expression and Serum NT-proBNP in Heart Failure With Preserved Ejection Fraction [J].
Hahn, Virginia S. ;
Knutsdottir, Hildur ;
Peterson, Tess E. ;
Kikuchi, Daniel ;
Vungarala, Soumya ;
Kass, David A. .
JACC-HEART FAILURE, 2024, 12 (07) :1306-1308
[35]   Using NT-proBNP as a criterion for heart failure hospitalization [J].
Tamizifar, Babak ;
Rismankarzadeh, Maryam .
JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (01) :111-113
[36]   NT-proBNP in heart failure: therapy decisions and monitoring [J].
Richards, M ;
Troughton, RW .
EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (03) :351-354
[37]   NT-proBNP and BNP: biomarkers for heart failure management [J].
Bettencourt, P .
EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (03) :359-363
[38]   The Potential Role of Salivary NT-proBNP in Heart Failure [J].
Rammos, Aidonis ;
Bechlioulis, Aris ;
Kalogeras, Petros ;
Watson, Chris J. ;
Salvo, Pietro ;
Lomonaco, Tommaso ;
Kardakari, Olga ;
Tripoliti, Evanthia E. ;
Goletsis, Yorgos ;
Fotiadis, Dimitris I. ;
Katsouras, Christos S. ;
Michalis, Lampros K. ;
Naka, Katerina K. .
LIFE-BASEL, 2023, 13 (09)
[39]   Interview: NT-proBNP: Therapy Monitoring in Heart Failure [J].
Leitner, H. ;
Moertl, Deddo .
JOURNAL FUR KARDIOLOGIE, 2018, 25 (7-8) :210-210
[40]   Correlation between NT-proBNP, functional capacity and ventilatory efficiency in patients with chronic heart failure [J].
Feliciano, J. Gomes ;
Soares, R. M. ;
Martins, S. ;
Fernandes, R. M. ;
Miranda, F. ;
Fiarresga, A. J. ;
Abreu, A. ;
Quininha, J. .
EUROPEAN HEART JOURNAL, 2005, 26 :744-744